Shun Hang (Henry) Chan, PhD

Henry joined Health Advances in 2021. He has a background in market analysis, opportunity prioritization, and financial modeling, focusing on life science tool sectors. 

Before joining Health Advances worked as a Postdoctoral Associate at Yale University Department of Genetics, a Blavatnik Associate at Yale Office of Cooperative Research, and a Research Specialist in Pharmacology at the University of Virginia School of Medicine. 

Henry completed a PhD in Genetics at Yale University School of Medicine and holds a BS in Biology and Chemistry, magna cum laude, Davis Scholar from the University of Virginia